drugset / Trial / NCT04117009

Effects of Remifentanil on Cardiac Function in Patients With Diastolic Dysfunction

NCT04117009

Phase 4 Unknown 30 enrolled Yeditepe University
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

In this study ASA 1, 2 individuals with grade 1 or 2 diastolic dysfunction will be recruited to assess the effects of Remifentanil infusion on left ventricular function evaluated with transthoracic echocardiagraphy.

Timeline

Start
2019-11-01
Primary completion
2020-06-01
Completion
2020-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 2 mg